SCHEMBL9949702

SCHEMBL9949702

CC(c1cccc(C=O)c1)C1CCCCC1

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
IDO1 P14902 2/20 0.38
ALDH1A1 P00352 2/20 0.37
DRD2 P14416 1/20 0.36
DRD1 P21728 1/20 0.36
DRD4 P21917 1/20 0.36
DRD5 P21918 1/20 0.36
DRD3 P35462 1/20 0.36
LMNA P02545 2/20 0.36
GAA P10253 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
EPHX1 P07099 3/20 0.35
SLC6A2 P23975 2/20 0.35
SLC6A4 P31645 2/20 0.35
SLC6A3 Q01959 2/20 0.35
TYR P14679 1/20 0.34
UNG P13051 1/20 0.34
MCOLN3 Q8TDD5 1/20 0.34
CHRM3 P20309 1/20 0.34
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene SCHEMBL9951092 0.86 DRD1 (0.34) IDO1DRD2DRD1DRD4DRD5
SCHEMBL9949806 0.86 ALDH1A1 (0.36) IDO1ALDH1A1DRD2DRD1DRD4
SCHEMBL9950076 0.85 DRD2 (0.34) ALDH1A1DRD2DRD1DRD4DRD5
SCHEMBL9949871 0.82 DRD2 (0.36) ALDH1A1DRD2DRD1DRD4DRD5
SCHEMBL9950807 0.82 DRD2 (0.37) ALDH1A1DRD2DRD1DRD4DRD5
SCHEMBL9950075 0.81 DRD2 (0.34) ALDH1A1DRD2DRD1DRD4DRD5
SCHEMBL16399056 0.81 IDO1 (0.45) IDO1ALDH1A1DRD2DRD1DRD4
SCHEMBL9949515 0.80 DRD2 (0.38) ALDH1A1DRD2DRD1DRD4DRD5
SCHEMBL9950279 0.80 TYR (0.52) IDO1ALDH1A1LMNAEPHX1SLC6A2
SCHEMBL9950061 0.80 DRD2 (0.38) ALDH1A1DRD2DRD1DRD4DRD5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748078-B2 Cyclic compound, process for preparation thereof, radiation-sensitive composition, and method for formation of resist pattern MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2014-06-10 US disclosed
EP-2476662-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN Mitsubishi Gas Chemical Company, Inc. (JP) 2012-07-18 EP disclosed
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2012-06-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120164576-A1 CYCLIC COMPOUND, PROCESS FOR PREPARATION THEREOF, RADIATION-SENSITIVE COMPOSITION, AND METHOD FOR FORMATION OF RESIST PATTERN RAD1, RER1, REV1 IDO1 4161/4885ALDH1A1 1204/4885DRD2 2661/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.